245 related articles for article (PubMed ID: 16723348)
1. Contrast-induced nephropathy--prevention and risk reduction.
Lameire NH
Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
[TBL] [Abstract][Full Text] [Related]
2. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
Fishman EK; Reddan D
Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
[TBL] [Abstract][Full Text] [Related]
3. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists.
Reddan D; Fishman EK
Eur J Radiol; 2008 May; 66(2):235-45. PubMed ID: 17728089
[TBL] [Abstract][Full Text] [Related]
4. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
Solomon R; Dumouchel W
Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
[TBL] [Abstract][Full Text] [Related]
5. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
Feldkamp T; Kribben A
Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
[TBL] [Abstract][Full Text] [Related]
6. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
[TBL] [Abstract][Full Text] [Related]
7. Risk prediction of contrast-induced nephropathy.
McCullough PA; Adam A; Becker CR; Davidson C; Lameire N; Stacul F; Tumlin J;
Am J Cardiol; 2006 Sep; 98(6A):27K-36K. PubMed ID: 16949378
[TBL] [Abstract][Full Text] [Related]
8. Contrast-induced nephropathy: the wheel has turned 360 degrees.
Thomsen HS; Morcos SK; Barrett BJ
Acta Radiol; 2008 Jul; 49(6):646-57. PubMed ID: 18568557
[TBL] [Abstract][Full Text] [Related]
9. Recent issues in contrast-induced nephropathy.
Kitajima K; Maeda T; Watanabe S; Sugimura K
Int J Urol; 2011 Oct; 18(10):686-90. PubMed ID: 21834851
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and therapy strategies for contrast-induced nephropathy.
Toprak O; Cirit M
Ren Fail; 2006; 28(5):365-81. PubMed ID: 16825085
[TBL] [Abstract][Full Text] [Related]
12. Prevention of iodinated contrast-induced nephropathy.
Li JH; He NS
Chin Med J (Engl); 2011 Dec; 124(23):4079-82. PubMed ID: 22340345
[TBL] [Abstract][Full Text] [Related]
13. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
Cavusoglu E; Chhabra S; Marmur JD; Kini A; Sharma SK
Minerva Cardioangiol; 2004 Oct; 52(5):419-32. PubMed ID: 15514576
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of contrast-induced nephropathy.
Al-Ghonaim M; Pannu N
Tech Vasc Interv Radiol; 2006 Jun; 9(2):42-9. PubMed ID: 17482099
[TBL] [Abstract][Full Text] [Related]
15. Contrast medium-induced nephropathy: strategies for prevention.
Massicotte A
Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385
[TBL] [Abstract][Full Text] [Related]
16. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
Nyman U; Björk J; Aspelin P; Marenzi G
Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.
McCullough P
Catheter Cardiovasc Interv; 2006 Mar; 67(3):335-43. PubMed ID: 16489569
[TBL] [Abstract][Full Text] [Related]
18. [Contrast-induced nephropathy in coronarography of patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches].
Shamkhalova MSh; Zaĭtseva NV; Kurumova KO; Shestakova MV; Deev AD; Matskeplishvili ST; Tugeeva EF; Buziashvili IuI
Ter Arkh; 2009; 81(8):36-42. PubMed ID: 19799198
[TBL] [Abstract][Full Text] [Related]
19. [Contrast-induced nephropathy].
Santos RO; Malvar B; Silva R; Ramalho V; Pessegueiro P; Amoedo M; Aniceto J; Pires C
Acta Med Port; 2011; 24(5):809-20. PubMed ID: 22525634
[TBL] [Abstract][Full Text] [Related]
20. The clinical and renal consequences of contrast-induced nephropathy.
Finn WF
Nephrol Dial Transplant; 2006 Jun; 21(6):i2-10. PubMed ID: 16723349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
